Neurology Central

Neuroprotective therapies to be developed by Magnolia Neurosciences

Accelerator Life Science Partners (Accelerator; NY, USA), a leading life science investment and management firm, has announced that is has launched Magnolia Neurosciences Corporation (NY, USA), which is a company developing a new class of neuroprotective medicines.

The company was launched by Accelerator earlier this year and was co-funded by world-class researchers at the University of Texas MD Anderson Cancer Center (TX, USA). Magnolia Neurosciences will further develop discoveries made by scientists at MD Anderson and the Neurodegeneration Consortium.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.